Pulmonx CFO Sung resigns; McKune interim CFO; Q3 revenue prelim ~$17.6M (+30% YoY)

Pulmonx Corp

CFO Derrick Sung resigned effective Oct 10, 2023 to pursue other opportunity; no disagreement with company.
John McKune (VP, Corp Controller) appointed Interim CFO; receives $75k cash bonus and $75k RSU grant.
Preliminary Q3 2023 revenue ~$17.6M, up ~30% YoY, a record quarter.
Search for permanent CFO initiated; Sung remains advisory through Oct 31, then consulting through Mar 2024.

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Derrick Sung

Chief Financial Officer

LUNG · Pulmonx Corp

Effective: 2023-10-10
Successor: John McKune
Filed: October 10, 2023, 7:59 PM ET

On October 6, 2023, Derrick Sung, Ph.D., Chief Financial Officer of the Company, stepped down from his position, effective October 10, 2023 (the “ Effective Date ”), to pursue a new business opportunity.

Appointed (interim)

John McKune

Interim Chief Financial Officer

LUNG · Pulmonx Corp

Effective: 2023-10-10
Filed: October 10, 2023, 7:59 PM ET

John McKune, Vice President, Corporate Controller of the Company, was appointed by the Board of Directors of the Company (the “ Board ”) to serve as the Interim Chief Financial Officer of the Company, effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pulmonx Corp reported third quarter 2023 results: revenue approximately $17.6 million.

Period: third quarter 2023
Revenue: approximately $17.6 million
Result: preliminary results

Exact text from the filing

Preliminary, unaudited third quarter 2023 revenue expected to be approximately $17.6 million

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Derrick Sung resigned as Chief Financial Officer at Pulmonx Corp.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On October 6, 2023, Derrick Sung, Ph.D., Chief Financial Officer of the Company, stepped down from his position, effective October 10, 2023 (the “ Effective Date ”), to pursue a new business opportunity.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

John McKune was appointed as Interim Chief Financial Officer at Pulmonx Corp.

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

John McKune, Vice President, Corporate Controller of the Company, was appointed by the Board of Directors of the Company (the “ Board ”) to serve as the Interim Chief Financial Officer of the Company, effective as of the Effective Date.

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

Pulmonx Corp filing history →

Source: SEC EDGAR

accession 0001193125-23-253468

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.